These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15719560)

  • 1. [Diphosphonates in solid malignant tumors].
    Kamby C; Pedersen L; Kristensen B
    Ugeskr Laeger; 2005 Jan; 167(4):379-82. PubMed ID: 15719560
    [No Abstract]   [Full Text] [Related]  

  • 2. Should oral bisphosphonates be standard of care in women with early breast cancer?
    Clemons M; Verma S
    Breast Cancer Res Treat; 2005 Apr; 90(3):315-8. PubMed ID: 15830146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates as anticancer drugs.
    Mundy GR; Yoneda T
    N Engl J Med; 1998 Aug; 339(6):398-400. PubMed ID: 9691109
    [No Abstract]   [Full Text] [Related]  

  • 4. [Is pamidronate or clodronate better?].
    Adam Z
    Vnitr Lek; 2002 Apr; 48(4):357. PubMed ID: 12075601
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of bisphosphonates in the treatment of prostate cancer.
    Parker CC
    BJU Int; 2005 May; 95(7):935-8. PubMed ID: 15839907
    [No Abstract]   [Full Text] [Related]  

  • 6. Clodronate in metastatic breast cancer.
    Panasci LC; Sandor V; Melnychuk D
    N Engl J Med; 1998 Dec; 339(26):1940-1; author reply 1941. PubMed ID: 9874608
    [No Abstract]   [Full Text] [Related]  

  • 7. Clodronate in metastatic breast cancer.
    Meli M; Rausa L
    N Engl J Med; 1998 Dec; 339(26):1940; author reply 1941. PubMed ID: 9874607
    [No Abstract]   [Full Text] [Related]  

  • 8. Bisphosphonates as adjuvant therapy.
    Shapiro CL
    Clin Adv Hematol Oncol; 2009 May; 7(5):319-20. PubMed ID: 19521319
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant bisphosphonates in breast cancer: are we witnessing the emergence of a new therapeutic strategy?
    Coleman RE
    Eur J Cancer; 2009 Jul; 45(11):1909-15. PubMed ID: 19447606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates for care and cure.
    Body JJ
    Eur J Cancer; 2009 Sep; 45 Suppl 1():396-7. PubMed ID: 19775644
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of bisphosphonates in prostatic cancer.
    Mason MD; Glaholm J; Dearnaley DP
    Clin Oncol (R Coll Radiol); 1994; 6(2):77-8. PubMed ID: 8018576
    [No Abstract]   [Full Text] [Related]  

  • 12. Bisphosphonates in adjuvant treatment of early breast cancer.
    ; Harbeck N; von Minckwitz G; Thürlimann B
    Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S1. PubMed ID: 20427026
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of dichloromethylene diphosphonate in metastatic bone disease.
    Jung A; van Ouwenaller C; Chantraine A; Donath A; Rosini S
    N Engl J Med; 1981 Aug; 305(6):343-4. PubMed ID: 6454076
    [No Abstract]   [Full Text] [Related]  

  • 14. Sowing the soil for cure? Results of the ABCSG-12 trial open a new chapter in the evolving adjuvant bisphosphonate story in early breast cancer.
    Bedard PL; Body JJ; Piccart-Gebhart MJ
    J Clin Oncol; 2009 Sep; 27(25):4043-6. PubMed ID: 19652062
    [No Abstract]   [Full Text] [Related]  

  • 15. [Expanding the possibilities of using biphosphonates for prophylaxis and treatment of osteal complications in malignant metastasis].
    Svishchenko IuA; Shimanovskiĭ NL
    Eksp Klin Farmakol; 2004; 67(6):66-71. PubMed ID: 15707020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical treatment of bone metastases].
    Tubiana-Hulin M
    Bull Cancer Radiother; 1996; 83(4):299-304. PubMed ID: 9081331
    [No Abstract]   [Full Text] [Related]  

  • 17. Bisphosphonates spearhead new approach to treating bone metastases.
    Bankhead C
    J Natl Cancer Inst; 1997 Jan; 89(2):115-6. PubMed ID: 8998176
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical efficacy and safety of zoledronic acid in prostate and breast cancer.
    Doggrell SA
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1211-8. PubMed ID: 19761424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
    Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE
    J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bisphosphonate for treatment of advanced breast cancers].
    Kohno N; Kitazawa S
    Nihon Rinsho; 2000 Apr; 58 Suppl():345-51. PubMed ID: 11026017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.